PPP
ABBV icon

Private Portfolio Partners’s AbbVie ABBV Stock Holding History

Private Portfolio Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$1.8M Sell
10,154
-122
-1% -$22.4K 0.33% 53
2024
Q3 		$2.03M Buy
10,276
+34
+0.3% +$6.35K 0.38% 51
2024
Q2 		$1.76M Sell
10,242
-143
-1% -$23.7K 1.43% 18
2024
Q1 		$1.89M Sell
10,385
-253
-2% -$43.6K 0.39% 50
2023
Q4 		$1.65M Buy
10,638
+43
+0.4% +$6.27K 0.38% 49
2023
Q3 		$1.58M Sell
10,595
-235
-2% -$34.5K 0.41% 49
2023
Q2 		$1.46M Sell
10,830
-91
-0.8% -$13.3K 0.37% 56
2023
Q1 		$1.74M Sell
10,921
-313
-3% -$47.9K 0.47% 42
2022
Q4 		$1.82M Sell
11,234
-182
-2% -$27.9K 0.48% 45
2022
Q3 		$1.53M Buy
11,416
+50
+0.4% +$7.17K 0.44% 49
2022
Q2 		$1.74M Sell
11,366
-28
-0.2% -$4.28K 0.49% 46
2022
Q1 		$1.85M Sell
11,394
-8
-0.1% -$1.16K 0.46% 47
2021
Q4 		$1.54M Buy
11,402
+271
+2% +$32K 0.4% 56
2021
Q3 		$1.2M Buy
11,131
+1,137
+11% +$130K 0.34% 66
2021
Q2 		$1.13M Buy
9,994
+275
+3% +$31K 0.33% 70
2021
Q1 		$1.05M Buy
9,719
+142
+1% +$15.2K 0.34% 68
2020
Q4 		$1.03M Sell
9,577
-298
-3% -$28.6K 0.36% 65
2020
Q3 		$865K Buy
9,875
+316
+3% +$29.8K 0.35% 65
2020
Q2 		$938K Buy
9,559
+2,079
+28% +$183K 0.43% 57
2020
Q1 		$570K Sell
7,480
-384
-5% -$32.7K 0.3% 86
2019
Q4 		$696K Buy
7,864
+266
+4% +$22.1K 0.3% 87
2019
Q3 		$576K Buy
7,598
+1,302
+21% +$89.3K 0.27% 94
2019
Q2 		$458K Buy
6,296
+384
+6% +$30.2K 0.2% 130
2019
Q1 		$477K Buy
5,912
+31
+0.5% +$2.54K 0.25% 103
2018
Q4 		$542K Buy
+5,881
New +$517K 0.33% 78

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Private Portfolio Partners's ABBV Position: Q4 2024 in Review

Private Portfolio Partners reduced its AbbVie (ABBV) stake by 1.2% in Q4 2024, selling an estimated $22.4K and leaving 10,154 shares worth $1.8M. The position accounts for 0.33% of the portfolio, ranked #53.

Private Portfolio Partners first reported a position in ABBV in Q4 2018 and has held it in 25 quarters since. The position peaked at $2.03M in Q3 2024. 3,744 funds tracked by Wall St. Rank hold ABBV as of Q4 2024.

  • Private Portfolio Partners held 10,154 shares of AbbVie worth $1.8M as of Q4 2024.
  • Private Portfolio Partners sold 122 AbbVie shares in Q4 2024, an estimated $22.4K.
  • AbbVie made up 0.33% of Private Portfolio Partners's portfolio in Q4 2024, its #53 holding.
  • Private Portfolio Partners first reported a position in AbbVie in Q4 2018 and has held it in 25 quarters since.
  • Private Portfolio Partners's AbbVie position peaked at $2.03M in Q3 2024.
  • 3,744 funds tracked by Wall St. Rank held AbbVie as of Q4 2024.

Based on Private Portfolio Partners's 13F filing for Q4 2024, filed 12 Feb 2025.